0 items

in your cart

  • Search for Medications
  • Viewcart | Checkout
  • Manage Account
  • Click-to-Call  

Prescription Drug Search

Search for a drug:


Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about GlobalPharmacyMeds.to

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Afatinib:

  • Antigua and Barbuda
  • Aruba
  • Australia
  • Bolivia
  • Bulgaria
  • Colombia
  • Denmark
  • El Salvador
  • Finland
  • Georgia
  • Germany
  • Gibraltar
  • Grenada
  • Guatemala
  • Hong Kong
  • Iceland
  • India
  • Iran
  • Iraq
  • Ireland
  • Italy
  • Korea, Republic of
  • Korea, South
  • Latvia
  • Lebanon
  • Liechtenstein
  • Morocco
  • Paraguay
  • Philippines
  • Poland
  • Qatar
  • Saudi Arabia
  • Serbia
  • Slovakia
  • Sri Lanka
  • Switzerland
  • Tunisia
  • Turkey
  • United Kingdom, UK
  • United States, US
View All Countries

Latest news releases on Afatinib:

Afatinib - Wikipedia

Afatinib, sold under the brand name Gilotrif among others, is a medication used to treat non-small cell lung carcinoma (NSCLC). It blocks the formation of new blood vessels (angiogenesis) by the cancer, thus preventing the cancer from growing. It belongs to the tyrosine kinase inhibitor family of medications. It is taken by mouth.

Afatinib – Wikipedia

Klinische Angaben Anwendungsgebiete (Indikationen) Afatinib ist ein von der FDA 2013 zugelassener Wirkstoff zur Behandlung bei erwachsenen Patienten mit lokal fortgeschrittenem und/oder metastasiertem nicht-kleinzelligen Bronchialkarzinom (NSCLC = non small cell lung carcinoma) mit aktivierenden EGFR-Mutationen.

Afatinib in Locally Advanced and Metastatic Chordoma ...

In this phase 2, single arm trial patients with locally advanced or metastatic, pathologically proven, EGFR expressing chordoma will be treated with afatinib.

DRUG NAME: Afatinib - BC Cancer

has been reported in 96% of patients receiving afatinib. Onset of diarrhea usually occurs within the first 2 weeks of treatment, with grade 3 diarrhea developing most frequently within the first 6 weeks.

肺癌藥妥復克5月納健保--Afatinib(妥復克 ...

衛生福利部健保署今日公告,自103年5月1日起,一項用於治療非小細胞肺癌的第一線標靶新藥妥復克(afatinib)將納入健保給付。 妥復克納入健保給付後,將增添晚期或轉移性非小細胞肺癌的治療選擇,其支付價每顆為1,4...

Afatinib as First-line Treatment of Older Patients With ...

Background. Afatinib is approved in the US, Europe, and several other regions for first-line treatment for epidermal growth factor receptor mutation-positive (EGFRm +) non-small-cell lung cancer (NSCLC).

Afatinib « ALCASE Italia

AFATINIB (Giotrif ®) Ultimo aggiornamento: 30-11-13: Nome commerciale: GIOTRIF ® Compagnia farmaceutica produttrice: Sviluppato dalla Boehringer-Ingelheim, è stato approvato per l’uso umano sia dalla europea EMA che dall’americana FDA, per il trattamento dei tumori polmonari non a piccole celleule (NSCLC) con mutazione EGFR.

Giotrif 20 mg film-coated tablets - Summary of Product ...

GIOTRIF 20 mg film-coated tablets. One film-coated tablet contains 20 mg afatinib (as dimaleate). Excipient with known effect. One film-coated tablet contains 118 mg lactose (as monohydrate).

Afatinib and Selumetinib in Advanced KRAS Mutant and ...

Afatinib and Selumetinib in Advanced KRAS Mutant and PIK3CA Wildtype Non-small Cell Lung Cancer (M14AFS)

European Medicines Agency - Find medicine - Giotrif

European Union agency responsible for the protection of public and animal health through the scientific evaluation and supervision of medicines.

Customer Service
1-866-799-3435 (Use ref# 10786) | Contact Form
Copyright © 2018 GlobalPharmacyMeds.to All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK